KLINICKÁ FARMAKOLOGIE A FARMACIE / Klin Farmakol Farm. 2024;38(1):15-21 / www.klinickafarmakologie.cz 20 HLAVNÍ TÉMA Medication adherence – the way to understand patients ans.This delegation provides physicians with time to focus on understanding and addressing patient medication adherence patterns (45). Effective doctor-patient communication leads to a 19 % higher patient adherence rate, as evidenced by 106 studies with compelling statistical significance. Patients with poorly communicating doctors face a 47 % higher risk of non-adherence (75). By extending clinical services and embracing a patient-centered approach, the pharmacy profession holds a key role. It can enhance the coordination of the entire medication process by consulting patients on medication adherence. Hepler and Strand highlight the key term covenant which represents the connection between the patient and the pharmacist. This is the bond that cements the therapeutic relationship (76). The role in community pharmacies, particularly through direct patient counseling, has proven crucial for enhancing medication adherence. Such interactions not only educate patients about their treatments and conditions but also improve medication schedules, leading to improved adherence. Boeni et al. underline the observed evidence on the significant impact that targeted counseling by pharmacists has on medication adherence and persistence. However, reports suggest that counseling practices in community pharmacies are limited. Patient counseling in community pharmacies often assumes a minor role, with a tendency towards nonmedical or product-centered communication rather than a patient-centered approach (77). In summary, pharmacists have significant opportunities to overcome conventional obstacles, utilizing their expertise to enhance patient understanding, adherence, and clinical outcomes. It can be accomplished by providing counseling and education while also enhancing their professional growth. The requirements are evident, pharmacists have a well-documented role, and a promising opportunity awaits (76). Conclusion and perspectives Therapeutic care is founded on respect for the patient’s individuality and stands in clear contrast to paternalistic and authoritarian approaches. It is essential to rethink medication adherence, encouraging a shift from viewing it as a strict enforcement by the practitioner’s authority to seeing it as a joint effort involving everyone committed to resolving a specific issue. Non-adherence to medication negatively impacts health and increases healthcare costs. It is crucial for relevant parties to first acknowledge this issue’s existence and properly understand its primary causes. Prioritizing medication adherence in policy discussions is crucial to raise awareness and implement effective solutions. Future efforts should focus on improving methods for measuring and screening medication adherence, with validated instruments, to better understand and address the nuances of this issue. Additionally, interventions such as multidrug punch cards and medication charts show their potential in enhancing adherence, particularly in polypharmacy. A collaborative, patient-centered approach in healthcare is vital, empowering pharmacists to play a more integral role. This approach, combined with effective adherence measurement and screening, holds the key to improve patient medication adherence. REFERENCES 1. Jimmy B, Jose J. Patient Medication Adherence: Measures in Daily Practice. Oman Med J. 2011;26(3):155-159. 2. Vervloet M, Linn AJ, van Weert JCM, et al. The effectiveness of interventions using electronic reminders to improve adherence to chronic medication: A systematic review of the literature. Journal of the American Medical Informatics Association. 2012;19(5):696-704. 3. Baryakova TH, Pogostin BH, Langer R, et al. Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems. Nat Rev Drug Discov. 2023;22(5):387-409. 4. Bosworth HB, Granger BB, Mendys P, et al. Medication adherence: A call for action. Am Heart J. 2011;162(3):412-424. 5. Arbuckle C, Tomaszewski D, Brown L, et al. Exploring the relationship of digital information sources and medication adherence. Comput Biol Med. 2019;109:303-310. 6. Partridge AH, Avorn J, Wang PS, et al. Adherence to Therapy With Oral Antineoplastic Agents, JNCI: Journal of the National Cancer Institute. 2002;94(9):652-661. 7. Khan R, Socha-Dietrich K. Investing in medication adherence improves health outcomes and health system efficiency: Adherence to medicines for diabetes, hypertension, and hyperlipidaemia. OECD Health Working Papers. 2018;(105). 8. Cutler RL, Fernandez-Llimos F, Frommer M, et al. Economic impact of medication non-adherence by disease groups: A systematic review. BMJ Open. 2018;8(1). 9. Valverde-Merino MI, Martinez-Martinez F, Garcia-Mochon L, et al. Cost-utility analysis of a medication adherence management service alongside a cluster randomized control trial in community pharmacy. Patient Prefer Adherence. 2021;15:2363-2376. 10. Blaschke TF, Osterberg L, Vrijens B, et al. Adherence to medications: Insights arising from studies on the unreliable link between prescribed and actual drug dosing histories. Annu Rev Pharmacol Toxicol. 2012;52:275-301. 11. Dietrich F, Polymeris AA, Albert V, et al. Intake reminders are effective in enhancing adherence to direct oral anticoagulants in stroke patients: a randomised cross-over trial (MAAESTRO study). J Neurol. 2023 Oct 13. 12. Raparelli V PMCRLGLDBS. Adherence to oral anticoagulant therapy in patients with atrial fibrillation. Focus on non-vitamin K antagonist oral anticoagulants. Thromb Haemost. 2017;117(2):209-218. 13. Kim D, Yang PS, Jang E, et al. The optimal drug adherence to maximize the efficacy and safety of non-vitamin K antagonist oral anticoagulant in real-world atrial fibrillation patients. Europace. 2020;22(4):547-557. 14. Solla-Ruiz I, Villanueva-Benito I, Paredes-Galán E, et al. Differences between patient-driven adherence to vitamin K antagonists and direct oral anticoagulants. Do few missed doses matter? ACO-MEMS Study. Thromb Res. 2019;179:20-27. 15. Fetzer BC, Mupenda B, Lusiama J, et al. Barriers to and facilitators of adherence to pediatric antiretroviral therapy in a sub-Saharan setting: Insights from a qualitative study. AIDS Patient Care STDS. 2011;25(10):611-621. 16. Kvarnström K, Westerholm A, Airaksinen M, et al. Factors contributing to medication adherence in patients with a chronic condition: A scoping review of qualitative research. Pharmaceutics. 2021;13(7). 17. Pushpangadan M, Feely M. Once a Day is Best: Evidence or Assumption? The Relationship Between Compliance and Dosage Frequency in Older People. Drugs Aging. 1998;13(3):223-227. 18. Joyce GF. Understanding Primary Nonadherence. Am J Pharm Benefits. 2010;2(2):111-118. 19. Kardas P, Lewek P, Matyjaszczyk M. Determinants of patient adherence: a review of systematic reviews. Front Pharmacol. 2013;4:91. 20. Demonceau J, Ruppar T, Kristanto P, et al. Identification and assessment of adherence-enhancing interventions in studies assessing medication adherence through electronically compiled drug dosing histories: A systematic literature review and meta-analysis. Drugs. 2013;73(6):545-562. 21. Gossec L, Tubach F, Dougados M, et al. Reporting of adherence to medication in recent randomized controlled trials of 6 chronic diseases: a systematic literature review. Am J Med Sci. 2007;334(4):248-254. 22. Lehmann A, Aslani P, Ahmed R, et al. Assessing medication adherence: Options to consider. Int J Clin Pharm. 2014;36(1):55-69. 23. Nadery Y, Khorasani P, Feizi A, et al. Causes of nonadherence to treatment in people with myocardial infarction: Content analysis. J Educ Health Promot. 2021;10(1). 24. Wilhelmsen NC, Eriksson T. Medication adherence interventions and outcomes: An overview of systematic reviews. European Journal of Hospital Pharmacy. 2019;26(4):187-192. 25. Mason M, Cho Y, Rayo J, et al. Technologies for Medication Adherence Monitoring and Technology Assessment Criteria: Narrative Review. JMIR Mhealth Uhealth. 2022;10(3). 26. Park LG, Howie-Esquivel J, Dracup K. A quantitative systematic review of the efficacy of mobile phone interventions to improve medication adherence. J Adv Nurs. 2014;70(9):1932-1953. 27. Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther. 1999;21(6):1074-1090. 28. Basu S, Garg S, Sharma N, et al. Improving the assessment of medication adherence: Challenges and considerations with a focus on low-resource settings. Tzu Chi Med J. 2019;31(2):73-80.
RkJQdWJsaXNoZXIy NDA4Mjc=